In particular, the corresponding mutations are predicted to generate truncated proteins lacking the entire C-terminal cluster of conserved domains (including the SET domain) or significant portions of protein, thus disrupt their function and consequently deregulate the control of chromatin-based processes, ultimately leading to oncogenic transformation and the development of cancer. This evidence concerns the gene SET and cancer.